Emilia Butters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emilia Butters has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Gemma Bale
Department of Engineering, University of Cambridge
5 shared publications - Sruthi Srinivasan
Department of Engineering, University of Cambridge
4 shared publications Li Su
Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
3 shared publications- Li Su
University of Sheffield, Sheffield United Kingdom
3 shared publications - Deepshikha Acharya
University of Cambridge, Electrical Division, Department of Engineering, Cambridge, United Kingdom
2 shared publications Gemma Bale
Department of Engineering, University of Cambridge, Cambridge, United Kingdom
2 shared publications
Latest Publications
- Open Access
- 24 April 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
Brain network analysis in Alzheimer’s disease and mild cognitive impairment using high-density diffuse optical tomography
Dementia is associated with altered resting-state connectivity, measures of which could aid in its early detection and monitoring. High-density diffuse optical tomography (HD-DOT) is well suited to detect these alterations at scale due to its numerous practical advantages, but it has not yet been applied to dementia. In this study, we investigated resting-state functional connectivity across the prefrontal cortex in individuals with mild cognitive impairment (MCI, n = 22), Alzheimer’s disease (AD, n = 21), and in healthy controls (n = 22). A graph theoretical approach was taken to characterise both global and local patterns of prefrontal connectivity over a 5-minute resting period. We found that individuals with MCI exhibited denser and stronger networks with shorter path lengths, which normalised in AD, accompanied by a redistribution of network hubs that were less stable. These results perhaps reflect the recruitment of additional connections in the early stages of pathology to maintain short-term network stability, which is ultimately associated with less efficient and more fragmented network organisation in later stages. Following the demonstration of HD-DOT’s capacity to detect differences between healthy ageing and AD-type cognitive impairment, this work opens up new possibilities for the use of optical imaging in the study of this clinical population and HD-DOT’s potential for scalable clinical use.
- 24 April 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
Open AccessBrain network analysis in Alzheimer’s disease and mild cognitive impairment using high-density diffuse optical tomography
Dementia is associated with altered resting-state connectivity, measures of which could aid in its early detection and monitoring. High-density diffuse optical tomography (HD-DOT) is well suited to detect these alterations at scale due to its numerous practical advantages, but it has not yet been applied to dementia. In this study, we investigated resting-state functional connectivity across the prefrontal cortex in individuals with mild cognitive impairment (MCI, n = 22), Alzheimer’s disease (AD, n = 21), and in healthy controls (n = 22). A graph theoretical approach was taken to characterise both global and local patterns of prefrontal connectivity over a 5-minute resting period. We found that individuals with MCI exhibited denser and stronger networks with shorter path lengths, which normalised in AD, accompanied by a redistribution of network hubs that were less stable. These results perhaps reflect the recruitment of additional connections in the early stages of pathology to maintain short-term network stability, which is ultimately associated with less efficient and more fragmented network organisation in later stages. Following the demonstration of HD-DOT’s capacity to detect differences between healthy ageing and AD-type cognitive impairment, this work opens up new possibilities for the use of optical imaging in the study of this clinical population and HD-DOT’s potential for scalable clinical use.
- Open Access
Impact of Architecture Façade Design on Neurophysiological Stress Using Functional Near-Infrared Spectroscopy and Heart Rate Variability
Within industrialised and emerging industrialised economies people typically spend over 95% in industrialised and emerging industrialised economies typically spend over 95% of their time in built environments, yet the neurophysiological impact of architectural design remains poorly understood. While previous studies link visual patterning to cortical activity, the cortical-to-autonomic stress pathway remains largely unexplored—a key omission given that chronic stress contributes to allostatic overload. This study examined how architectural façade design influences neurophysiological stress through a multimodal approach combining functional near-infrared spectroscopy (fNIRS) to monitor occipital cortical activity with heart rate variability (HRV) as an index of autonomic regulation. Eighteen participants provided HRV data and subjective ratings for nine systematically varied façade images characterised by their deviation with respect to natural statistics, while a subset of twelve completed fNIRS recording due to signal acquisition constraints. Façade identity significantly affected discomfort, complexity, and interest ratings (), and deviation from natural statistics predicted all three measures (). Façade type also showed a small but significant effect on HRV (), although variance was dominated by individual differences. No stimulus-specific occipital fNIRS differences were observed. However, due to the limited sample size, further research is needed to verify this observed result. Whilst global generalisations cannot be drawn due to the small sample size, these pilot research findings indicate that façades deviating from natural image statistics influence perceptual comfort and may modestly modulate autonomic balance. However, the present data does not provide clear evidence of stimulus-specific cortical effects, which, if present, likely remain below the detection thresholds of the current protocol given its methodological constraints. This study highlights methodological hurdles and establishes a scalable framework for linking computational visual metrics to physiological responses, informing future investigations into how architectural features influence human health.Open AccessImpact of Architecture Façade Design on Neurophysiological Stress Using Functional Near-Infrared Spectroscopy and Heart Rate Variability
Within industrialised and emerging industrialised economies people typically spend over 95% in industrialised and emerging industrialised economies typically spend over 95% of their time in built environments, yet the neurophysiological impact of architectural design remains poorly understood. While previous studies link visual patterning to cortical activity, the cortical-to-autonomic stress pathway remains largely unexplored—a key omission given that chronic stress contributes to allostatic overload. This study examined how architectural façade design influences neurophysiological stress through a multimodal approach combining functional near-infrared spectroscopy (fNIRS) to monitor occipital cortical activity with heart rate variability (HRV) as an index of autonomic regulation. Eighteen participants provided HRV data and subjective ratings for nine systematically varied façade images characterised by their deviation with respect to natural statistics, while a subset of twelve completed fNIRS recording due to signal acquisition constraints. Façade identity significantly affected discomfort, complexity, and interest ratings (), and deviation from natural statistics predicted all three measures (). Façade type also showed a small but significant effect on HRV (), although variance was dominated by individual differences. No stimulus-specific occipital fNIRS differences were observed. However, due to the limited sample size, further research is needed to verify this observed result. Whilst global generalisations cannot be drawn due to the small sample size, these pilot research findings indicate that façades deviating from natural image statistics influence perceptual comfort and may modestly modulate autonomic balance. However, the present data does not provide clear evidence of stimulus-specific cortical effects, which, if present, likely remain below the detection thresholds of the current protocol given its methodological constraints. This study highlights methodological hurdles and establishes a scalable framework for linking computational visual metrics to physiological responses, informing future investigations into how architectural features influence human health. - Open Access
- 29 January 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 146
Transcutaneous Vagus Nerve Stimulation During Motor Activity in Healthy Volunteers: A High-Density Diffuse Optical Tomography Study
Background: Stroke is a leading cause of long-term disability worldwide. Non-invasive or transcutaneous auricular vagus nerve stimulation (taVNS) shows promise in promoting neuroplasticity and supporting motor recovery. There are currently no validated biomarkers of taVNS. High-density diffuse optical tomography (HD-DOT) is a portable neuroimaging technology that uses near-infrared light to map cortical activity via the quantification of changes in blood oxygenation. The aim of this study was to determine whether HD-DOT could detect motor task-related activity with concurrent taVNS. Methods: Thirty-one healthy participants completed right and left finger tapping tasks with concurrent sham (earlobe) and then active (tragus) taVNS in a within-subject block design. HD-DOT was recorded across the bilateral sensorimotor cortex using 36 sources and 48 detectors (1728 channels). Cortical reconstructions were parcellated and block-averaged task-related oxygenated and deoxygenated haemoglobin changes were compared between sham and active taVNS conditions. Results: In a group-level analysis, appropriate lateralised task-related haemodynamic responses were seen in the contralateral sensorimotor regions, demonstrating the validity of HD-DOT. Between-group comparisons showed no significant change in task-related activation during right finger tapping tasks under active vs. sham taVNS conditions. A non-significant redistribution of task-related activity to the right motor cortex was seen with left finger tapping under active taVNS compared to sham taVNS. Conclusions: Simultaneous recording of neural responses to taVNS during motor activity was feasible and well tolerated. Reliable task-related activation was recordable. Future studies of whole brain HD-DOT in people with stroke will help evaluate its potential as a biomarker in taVNS.
- 29 January 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 146
Open AccessTranscutaneous Vagus Nerve Stimulation During Motor Activity in Healthy Volunteers: A High-Density Diffuse Optical Tomography Study
Background: Stroke is a leading cause of long-term disability worldwide. Non-invasive or transcutaneous auricular vagus nerve stimulation (taVNS) shows promise in promoting neuroplasticity and supporting motor recovery. There are currently no validated biomarkers of taVNS. High-density diffuse optical tomography (HD-DOT) is a portable neuroimaging technology that uses near-infrared light to map cortical activity via the quantification of changes in blood oxygenation. The aim of this study was to determine whether HD-DOT could detect motor task-related activity with concurrent taVNS. Methods: Thirty-one healthy participants completed right and left finger tapping tasks with concurrent sham (earlobe) and then active (tragus) taVNS in a within-subject block design. HD-DOT was recorded across the bilateral sensorimotor cortex using 36 sources and 48 detectors (1728 channels). Cortical reconstructions were parcellated and block-averaged task-related oxygenated and deoxygenated haemoglobin changes were compared between sham and active taVNS conditions. Results: In a group-level analysis, appropriate lateralised task-related haemodynamic responses were seen in the contralateral sensorimotor regions, demonstrating the validity of HD-DOT. Between-group comparisons showed no significant change in task-related activation during right finger tapping tasks under active vs. sham taVNS conditions. A non-significant redistribution of task-related activity to the right motor cortex was seen with left finger tapping under active taVNS compared to sham taVNS. Conclusions: Simultaneous recording of neural responses to taVNS during motor activity was feasible and well tolerated. Reliable task-related activation was recordable. Future studies of whole brain HD-DOT in people with stroke will help evaluate its potential as a biomarker in taVNS.
- Open Access
- 3 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (9) , 1167
Can the Pupillary Light Reflex and Pupillary Unrest Be Used as Biomarkers of Parkinson’s Disease? A Systematic Review and Meta-Analysis
Background/Objectives: The pathological changes preceding the onset of Parkinson’s disease (PD) commence several decades before motor symptoms manifest, offering a potential window for identifying objective biomarkers for early diagnosis and disease monitoring. Among the primary non-motor features of PD is autonomic dysfunction; however, its precise assessment remains challenging, limiting its viability as a reliable biomarker. Both the pupillary light reflex (PLR) and pupillary unrest are regulated by autonomic pathways suggesting their potential as objective non-invasive indicators of the PD prodromal phase. This review systematically evaluates studies that compare PLR and pupillary unrest in individuals with PD and healthy controls to determine their utility as potential biomarkers of the disease. Methods: A systematic search strategy was designed to identify studies reporting PLR and pupillary unrest findings in PD patients. Searches were conducted across three databases (MEDLINE, Embase PsycINFO), supplemented by cross-referencing relevant studies found on Google Scholar. The literature search was last updated on 7 December 2020. Pupillometric parameters that permitted statistical synthesis included maximum constriction velocity (VMax), constriction amplitude (CAmp), and constriction latency (CL). Pooled incidence and effect sizes were determined using a random-effects model with an inverse variance DerSimonian–Laird estimator. The I2 statistic was used to assess study heterogeneity. When meta-analysis was not feasible, a qualitative analysis was undertaken. Results: The initial search yielded 219 references. Following deduplication and exclusion of ineligible studies, 31 papers were selected for review. Pupillometric data from 11 studies were incorporated into the meta-analysis. Effect sizes for PD patients were significant for VMax −0.92, (p < 0.01), CAmp −0.58, (p < 0.05), and CL 0.46, (p < 0.05). Measures of pupillary unrest were elevated in PD patients compared to controls, but evidence was limited to two studies. Conclusions: Pupillary constriction in response to light is characterised by reduced speed and amplitude in PD, with effect sizes suggesting potential clinical applicability. However, evidence regarding baseline pupillary variability remains insufficient, underlining the necessity for further research. Pupillary metrics represent a promising avenue for early PD detection, though their clinical utility is constrained by methodological heterogeneity and variations in disease duration among studies.
- 3 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (9) , 1167
Open AccessCan the Pupillary Light Reflex and Pupillary Unrest Be Used as Biomarkers of Parkinson’s Disease? A Systematic Review and Meta-Analysis
Background/Objectives: The pathological changes preceding the onset of Parkinson’s disease (PD) commence several decades before motor symptoms manifest, offering a potential window for identifying objective biomarkers for early diagnosis and disease monitoring. Among the primary non-motor features of PD is autonomic dysfunction; however, its precise assessment remains challenging, limiting its viability as a reliable biomarker. Both the pupillary light reflex (PLR) and pupillary unrest are regulated by autonomic pathways suggesting their potential as objective non-invasive indicators of the PD prodromal phase. This review systematically evaluates studies that compare PLR and pupillary unrest in individuals with PD and healthy controls to determine their utility as potential biomarkers of the disease. Methods: A systematic search strategy was designed to identify studies reporting PLR and pupillary unrest findings in PD patients. Searches were conducted across three databases (MEDLINE, Embase PsycINFO), supplemented by cross-referencing relevant studies found on Google Scholar. The literature search was last updated on 7 December 2020. Pupillometric parameters that permitted statistical synthesis included maximum constriction velocity (VMax), constriction amplitude (CAmp), and constriction latency (CL). Pooled incidence and effect sizes were determined using a random-effects model with an inverse variance DerSimonian–Laird estimator. The I2 statistic was used to assess study heterogeneity. When meta-analysis was not feasible, a qualitative analysis was undertaken. Results: The initial search yielded 219 references. Following deduplication and exclusion of ineligible studies, 31 papers were selected for review. Pupillometric data from 11 studies were incorporated into the meta-analysis. Effect sizes for PD patients were significant for VMax −0.92, (p < 0.01), CAmp −0.58, (p < 0.05), and CL 0.46, (p < 0.05). Measures of pupillary unrest were elevated in PD patients compared to controls, but evidence was limited to two studies. Conclusions: Pupillary constriction in response to light is characterised by reduced speed and amplitude in PD, with effect sizes suggesting potential clinical applicability. However, evidence regarding baseline pupillary variability remains insufficient, underlining the necessity for further research. Pupillary metrics represent a promising avenue for early PD detection, though their clinical utility is constrained by methodological heterogeneity and variations in disease duration among studies.
- Open Access
Brain Network Analysis in Alzheimer's Disease and Mild Cognitive Impairment using High-Density Diffuse Optical Tomography
Dementia is associated with altered resting state connectivity, measures of which could aid in its early detection and monitoring. High-density diffuse optical tomography (HD-DOT) is well-suited to detect these alterations at scale due to its numerous practical advantages, but it has not yet been applied to dementia. In this study, we investigated resting state functional connectivity across the prefrontal cortex in individuals with Mild Cognitive Impairment (MCI, n = 22), Alzheimer’s Disease (AD, n = 21), and in healthy controls (n = 22). A graph theoretical approach was taken to characterise both global and local patterns of connectivity over a five-minute resting period. We found that individuals with AD and MCI exhibited denser and stronger networks, with shorter path lengths, as well as a loss of consistent key network hubs with worsening cognitive impairment. These results indicate that networks in dementia are more globally connected, albeit in a disorganised manner, perhaps reflecting the recruitment of additional connections for short-term stability which may be ultimately damaging in the long-term. Following the demonstration of HD-DOT’s capacity to detect differences between healthy ageing and dementia, this work opens up new possibilities for the use of optical imaging in the study of this clinical population and HD-DOT’s potential for scalable clinical use.
Open AccessBrain Network Analysis in Alzheimer's Disease and Mild Cognitive Impairment using High-Density Diffuse Optical Tomography
Dementia is associated with altered resting state connectivity, measures of which could aid in its early detection and monitoring. High-density diffuse optical tomography (HD-DOT) is well-suited to detect these alterations at scale due to its numerous practical advantages, but it has not yet been applied to dementia. In this study, we investigated resting state functional connectivity across the prefrontal cortex in individuals with Mild Cognitive Impairment (MCI, n = 22), Alzheimer’s Disease (AD, n = 21), and in healthy controls (n = 22). A graph theoretical approach was taken to characterise both global and local patterns of connectivity over a five-minute resting period. We found that individuals with AD and MCI exhibited denser and stronger networks, with shorter path lengths, as well as a loss of consistent key network hubs with worsening cognitive impairment. These results indicate that networks in dementia are more globally connected, albeit in a disorganised manner, perhaps reflecting the recruitment of additional connections for short-term stability which may be ultimately damaging in the long-term. Following the demonstration of HD-DOT’s capacity to detect differences between healthy ageing and dementia, this work opens up new possibilities for the use of optical imaging in the study of this clinical population and HD-DOT’s potential for scalable clinical use.
- Open Access
- 1 February 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (S2) , 1-12
Mapping functional hemodynamic and metabolic responses to dementia: a broadband spectroscopy pilot study
SignificanceBroadband near-infrared spectroscopy (bNIRS) can simultaneously monitor several chromophores, including the oxidative state of cytochrome c-oxidase (oxCCO), an oxygen metabolism biomarker, the activity of which is altered in Alzheimer’s disease. Being a portable and noninvasive neuromonitoring technique, bNIRS could provide accessibility to brain-specific biomarkers and aid in the dementia diagnostic pathway.AimWe use bNIRS-recorded functional hemodynamic and oxCCO changes to assess their relevance in Alzheimer’s disease diagnosis.ApproachUsing a visual stimulus paradigm, we recorded functional changes in oxy-, deoxy-hemoglobin and oxCCO in three similarly aged cohorts: healthy controls (n=5), individuals with mild cognitive impairment (n=7), and individuals with early Alzheimer’s dementia (n=7). We then selected features from these functional responses to find the best correlation with clinical cognitive markers (cognitive and behavioral test scores and clinical diagnoses) using canonical correlation analysis (CCA).ResultsWe found individual variations in peak amplitude and time-to-peak for all the stimulus-evoked bNIRS signals across the three cohorts. CCA showed a strong correlation between bNIRS features and the clinical cognitive markers (r=0.902). However, repeating the same analysis by excluding the bNIRS oxCCO features leads to a significantly lower correlation (r=0.687) with the clinical markers.ConclusionsoxCCO could be a crucial biomarker, partly explaining cognitive differences with dementia. bNIRS uniquely provides a portable and noninvasive technique to monitor several chromophores simultaneously, including oxCCO, with potential future applications in diagnosing and tracking dementia progression.
- 1 February 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (S2) , 1-12
Open AccessMapping functional hemodynamic and metabolic responses to dementia: a broadband spectroscopy pilot study
SignificanceBroadband near-infrared spectroscopy (bNIRS) can simultaneously monitor several chromophores, including the oxidative state of cytochrome c-oxidase (oxCCO), an oxygen metabolism biomarker, the activity of which is altered in Alzheimer’s disease. Being a portable and noninvasive neuromonitoring technique, bNIRS could provide accessibility to brain-specific biomarkers and aid in the dementia diagnostic pathway.AimWe use bNIRS-recorded functional hemodynamic and oxCCO changes to assess their relevance in Alzheimer’s disease diagnosis.ApproachUsing a visual stimulus paradigm, we recorded functional changes in oxy-, deoxy-hemoglobin and oxCCO in three similarly aged cohorts: healthy controls (n=5), individuals with mild cognitive impairment (n=7), and individuals with early Alzheimer’s dementia (n=7). We then selected features from these functional responses to find the best correlation with clinical cognitive markers (cognitive and behavioral test scores and clinical diagnoses) using canonical correlation analysis (CCA).ResultsWe found individual variations in peak amplitude and time-to-peak for all the stimulus-evoked bNIRS signals across the three cohorts. CCA showed a strong correlation between bNIRS features and the clinical cognitive markers (r=0.902). However, repeating the same analysis by excluding the bNIRS oxCCO features leads to a significantly lower correlation (r=0.687) with the clinical markers.ConclusionsoxCCO could be a crucial biomarker, partly explaining cognitive differences with dementia. bNIRS uniquely provides a portable and noninvasive technique to monitor several chromophores simultaneously, including oxCCO, with potential future applications in diagnosing and tracking dementia progression.
- 15 February 2024
- Published by Springer Nature
- p. 351-357
Towards an Interpretable Functional Image-Based Classifier: Dimensionality Reduction of High-Density Diffuse Optical Tomography Data
- 15 February 2024
- Published by Springer Nature
- p. 351-357
Towards an Interpretable Functional Image-Based Classifier: Dimensionality Reduction of High-Density Diffuse Optical Tomography Data
- Open Access
- 24 June 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 90, 101992
A promising tool to explore functional impairment in neurodegeneration: A systematic review of near-infrared spectroscopy in dementia.
- 24 June 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 90, 101992
Open AccessA promising tool to explore functional impairment in neurodegeneration: A systematic review of near-infrared spectroscopy in dementia.
- Open Access
- 10 February 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 023514-13
Illuminating neurodegeneration: a future perspective on near-infrared spectroscopy in dementia research
Currently, 57.4 million individuals live with dementia worldwide with an estimated 152.8 million by 2050,1 so there is an urgent need to develop early-stage biomarkers and interventions for dementia. Defined in the International Classification of Diseases (11th Revision) (ICD-11) as an impairment in at least two cognitive domains of sufficient extent to cause impairments in functioning in daily activities, symptoms of dementia include problems with memory, language, executive function, and attention.2 The most common form of dementia is Alzheimer’s disease (AD), followed by vascular dementia (VaD), dementia with Lewy bodies (DLB), and fronto-temporal dementia (FTD). Aside from the individual pathophysiology of these disorders, dementia is ultimately associated with large-scale neuronal loss in brain areas that support cognitive function, though earlier cognitive impairment, likely caused by synaptic dysfunction, is thought to occur before such widespread atrophy.3 Neither the factors that contribute to this neuronal loss nor the possible targets for intervention are very well established. Early stages in the disease course, such as mild cognitive impairment (MCI) or subjective cognitive decline, may be a critical period for effective intervention in the development of dementia,4 in which a conversion rate to dementia of up to 12% a year has been observed.5 During this period, pathological changes are proposed to occur in the brain that increase the risk of progression to dementia.6 Current methods to detect and monitor dementia, particularly in early prodromal stages such as MCI, are rapidly developing. Recent advances include amyloid and tau brain imaging, the development of cerebrospinal fluid (CSF) biomarkers for tau and amyloid, and most recently blood biomarkers, all of which are available through the National Health Service in the UK. However, many of these biomarkers require validation in early stages, are currently limited to AD, and are not helpful for diagnosing VaD, DLB, or FTD. These biomarkers are also highly invasive, requiring radiation or a lumbar puncture, are expensive, and in the case of CSF and blood measurements, do not directly assess the target organ, i.e., the brain. Given the high misdiagnosis rates observed in dementia, attributed to factors including a lack of resources and attitudes toward diagnosis,7 the development of accessible, low-cost, and brain-specific biomarkers is urgently needed.
- 10 February 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 023514-13
Open AccessIlluminating neurodegeneration: a future perspective on near-infrared spectroscopy in dementia research
Currently, 57.4 million individuals live with dementia worldwide with an estimated 152.8 million by 2050,1 so there is an urgent need to develop early-stage biomarkers and interventions for dementia. Defined in the International Classification of Diseases (11th Revision) (ICD-11) as an impairment in at least two cognitive domains of sufficient extent to cause impairments in functioning in daily activities, symptoms of dementia include problems with memory, language, executive function, and attention.2 The most common form of dementia is Alzheimer’s disease (AD), followed by vascular dementia (VaD), dementia with Lewy bodies (DLB), and fronto-temporal dementia (FTD). Aside from the individual pathophysiology of these disorders, dementia is ultimately associated with large-scale neuronal loss in brain areas that support cognitive function, though earlier cognitive impairment, likely caused by synaptic dysfunction, is thought to occur before such widespread atrophy.3 Neither the factors that contribute to this neuronal loss nor the possible targets for intervention are very well established. Early stages in the disease course, such as mild cognitive impairment (MCI) or subjective cognitive decline, may be a critical period for effective intervention in the development of dementia,4 in which a conversion rate to dementia of up to 12% a year has been observed.5 During this period, pathological changes are proposed to occur in the brain that increase the risk of progression to dementia.6 Current methods to detect and monitor dementia, particularly in early prodromal stages such as MCI, are rapidly developing. Recent advances include amyloid and tau brain imaging, the development of cerebrospinal fluid (CSF) biomarkers for tau and amyloid, and most recently blood biomarkers, all of which are available through the National Health Service in the UK. However, many of these biomarkers require validation in early stages, are currently limited to AD, and are not helpful for diagnosing VaD, DLB, or FTD. These biomarkers are also highly invasive, requiring radiation or a lumbar puncture, are expensive, and in the case of CSF and blood measurements, do not directly assess the target organ, i.e., the brain. Given the high misdiagnosis rates observed in dementia, attributed to factors including a lack of resources and attitudes toward diagnosis,7 the development of accessible, low-cost, and brain-specific biomarkers is urgently needed.
- Open Access
A systematic review of near-infrared spectroscopy in dementia
Objectives: This review aimed to evaluate previous studies using Near-infrared spectroscopy (NIRS) in dementia by summarising the results, determining the consensus in the literature, and delineating if, and how, NIRS experimental and analysis methods may be improved for future studies in dementia. Methods: Three databases (PsychINFO, Medline, Embase) were searched for original research studies using NIRS in dementia and prodromal disease stages. We included both observational and randomised control trials, and studies published in English. Animal studies, conference abstracts, and reviews were excluded. Results: From 759 identified records, 80 studies using NIRS in dementia and prodromal populations across a range of activation tasks testing memory (28), word retrieval (22), and motor (7) and visuo-spatial function (4), as well as in the resting state (29) were evaluated. Across these cognitive domains, dementia patients generally showed a blunted haemodynamic response, often localised to frontal regions of interest, and a lack of task-appropriate frontal lateralisation. Prodromal stages, such as Mild Cognitive Impairment, revealed mixed results and were associated with either diminished responses or hyperactivity, accompanied by reduced cognitive function, the latter suggesting a possible compensatory neural response which is not present at the dementia stage. Conclusion: There is clear evidence of alterations in brain oxygenation in both dementia and prodromal stages across a range of cognitive domains and in the resting state, indicating an ability of NIRS to distinguish dementia from healthy ageing, or at-risk populations. A consensus as to the nature of these changes, however, is difficult to reach due to a lack of standardisation in optical techniques and processing methods. Further studies are required exploring more naturalistic settings and in a wider range of dementia subtypes.
Open AccessA systematic review of near-infrared spectroscopy in dementia
Objectives: This review aimed to evaluate previous studies using Near-infrared spectroscopy (NIRS) in dementia by summarising the results, determining the consensus in the literature, and delineating if, and how, NIRS experimental and analysis methods may be improved for future studies in dementia. Methods: Three databases (PsychINFO, Medline, Embase) were searched for original research studies using NIRS in dementia and prodromal disease stages. We included both observational and randomised control trials, and studies published in English. Animal studies, conference abstracts, and reviews were excluded. Results: From 759 identified records, 80 studies using NIRS in dementia and prodromal populations across a range of activation tasks testing memory (28), word retrieval (22), and motor (7) and visuo-spatial function (4), as well as in the resting state (29) were evaluated. Across these cognitive domains, dementia patients generally showed a blunted haemodynamic response, often localised to frontal regions of interest, and a lack of task-appropriate frontal lateralisation. Prodromal stages, such as Mild Cognitive Impairment, revealed mixed results and were associated with either diminished responses or hyperactivity, accompanied by reduced cognitive function, the latter suggesting a possible compensatory neural response which is not present at the dementia stage. Conclusion: There is clear evidence of alterations in brain oxygenation in both dementia and prodromal stages across a range of cognitive domains and in the resting state, indicating an ability of NIRS to distinguish dementia from healthy ageing, or at-risk populations. A consensus as to the nature of these changes, however, is difficult to reach due to a lack of standardisation in optical techniques and processing methods. Further studies are required exploring more naturalistic settings and in a wider range of dementia subtypes.